20-32805997-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_006892.4(DNMT3B):​c.2302-212T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.796 in 151,934 control chromosomes in the GnomAD database, including 49,161 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.80 ( 49161 hom., cov: 29)

Consequence

DNMT3B
NM_006892.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.984

Publications

10 publications found
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]
DNMT3B Gene-Disease associations (from GenCC):
  • immunodeficiency-centromeric instability-facial anomalies syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency-centromeric instability-facial anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 20-32805997-T-C is Benign according to our data. Variant chr20-32805997-T-C is described in ClinVar as Benign. ClinVar VariationId is 1170169.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.972 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006892.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
NM_006892.4
MANE Select
c.2302-212T>C
intron
N/ANP_008823.1Q9UBC3-1
DNMT3B
NM_175850.3
c.2278-212T>C
intron
N/ANP_787046.1Q9UBC3-6
DNMT3B
NM_175848.2
c.2242-212T>C
intron
N/ANP_787044.1Q9UBC3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
ENST00000328111.6
TSL:1 MANE Select
c.2302-212T>C
intron
N/AENSP00000328547.2Q9UBC3-1
DNMT3B
ENST00000201963.3
TSL:1
c.2278-212T>C
intron
N/AENSP00000201963.3Q9UBC3-6
DNMT3B
ENST00000348286.6
TSL:1
c.2172-1765T>C
intron
N/AENSP00000337764.2Q9UBC3-3

Frequencies

GnomAD3 genomes
AF:
0.796
AC:
120864
AN:
151816
Hom.:
49099
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.948
Gnomad AMI
AF:
0.874
Gnomad AMR
AF:
0.786
Gnomad ASJ
AF:
0.746
Gnomad EAS
AF:
0.995
Gnomad SAS
AF:
0.804
Gnomad FIN
AF:
0.788
Gnomad MID
AF:
0.680
Gnomad NFE
AF:
0.694
Gnomad OTH
AF:
0.779
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.796
AC:
120987
AN:
151934
Hom.:
49161
Cov.:
29
AF XY:
0.801
AC XY:
59425
AN XY:
74224
show subpopulations
African (AFR)
AF:
0.949
AC:
39337
AN:
41468
American (AMR)
AF:
0.786
AC:
11997
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.746
AC:
2588
AN:
3468
East Asian (EAS)
AF:
0.995
AC:
5131
AN:
5158
South Asian (SAS)
AF:
0.803
AC:
3851
AN:
4798
European-Finnish (FIN)
AF:
0.788
AC:
8301
AN:
10540
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.694
AC:
47142
AN:
67928
Other (OTH)
AF:
0.779
AC:
1646
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1155
2310
3464
4619
5774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.722
Hom.:
32897
Bravo
AF:
0.804
Asia WGS
AF:
0.906
AC:
3148
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.77
DANN
Benign
0.32
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4911263; hg19: chr20-31393803; API